120 related articles for article (PubMed ID: 29128083)
21. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
Magoni M; Ekra KD; Aka LN; Sita KS; Kanga K
Ann Trop Med Parasitol; 2009 Sep; 103(6):519-27. PubMed ID: 19695157
[TBL] [Abstract][Full Text] [Related]
22. [Etiological factors of hepatocellular carcinoma in Abidjan (Ivory Coast) (author's transl)].
Le Bras M; Ticolat R; Clerc M; Loubière R; Beda B; Bertrand E
Gastroenterol Clin Biol; 1978; 2(8-9):679-88. PubMed ID: 213339
[No Abstract] [Full Text] [Related]
23. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P;
Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of HBs antigen carriage in a population of national Gendarmerie recruits in Ivory Coast in 2008].
Kra O; N'dri N; Ouattara B; Kadjo K; Aba T; Bissagnéné E
Med Sante Trop; 2012; 22(2):219-20. PubMed ID: 23281537
[TBL] [Abstract][Full Text] [Related]
25. HIV / AIDS country profile: Cote d'Ivoire. Risk analysis.
Da Camara-gomes F
AIDS Anal Afr; 1997 Apr; 7(2):12-4. PubMed ID: 12290341
[TBL] [Abstract][Full Text] [Related]
26. Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
Parikh ND; Fu S; Rao H; Yang M; Li Y; Powell C; Wu E; Lin A; Xing B; Wei L; Lok ASF
Dig Dis Sci; 2017 Nov; 62(11):3243-3253. PubMed ID: 28948495
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
28. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
[TBL] [Abstract][Full Text] [Related]
29. Acceptance of HIV in Cote d'Ivoire earns praise.
AIDS Wkly Plus; 1996 Apr; ():15-6. PubMed ID: 12290906
[TBL] [Abstract][Full Text] [Related]
30. Viral hepatitis and hepatocellular carcinoma.
Sallie R; Di Bisceglie AM
Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
[TBL] [Abstract][Full Text] [Related]
31. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
32. Tumor size and stage of breast cancer in Côte d'Ivoire and Republic of Congo - Results from population-based cancer registries.
Islami F; Lortet-Tieulent J; Okello C; Adoubi I; Mbalawa CG; Ward EM; Parkin DM; Jemal A
Breast; 2015 Dec; 24(6):713-7. PubMed ID: 26371692
[TBL] [Abstract][Full Text] [Related]
33. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
[TBL] [Abstract][Full Text] [Related]
34. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
[TBL] [Abstract][Full Text] [Related]
37. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
38. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.
Roberts SK; Kemp W
J Gastroenterol Hepatol; 2007 Feb; 22(2):191-6. PubMed ID: 17295870
[TBL] [Abstract][Full Text] [Related]
40. [Epidemiology of malignant liver tumors].
Rodella S; Picoco C
Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
